Skip Navigation

Waithaka Mwangi

Associate Professor


Phone: (979) 845-4615

Mailstop: 4467

Department: VTPB

Photo of Mwangi, Waithaka


  • Collaborates with researchers at the International Livestock Research Institute (ILRI) in Nairobi, Kenya in areas of diagnostics and vaccine development of African swine fever an d East Coast fever.
  • Collaborates with researchers at the Laboratorio de Inmunología, Centro de Investigación en Alimentación y Desarrollo in Sonora, Mexico trying to develop an effective vaccine against Porcine reproductive and respiratory syndrome virus
  • Collaborates with researchers at the Instituto de Virología, Buenos Aires, Argentina in developing an effective vaccine against Foot and Mouth Dissease
  • Collaborates with researchers at The Roslin Institute, University of Edinburgh, UK in the area of vaccine efficacy enhancement


  • Post-Doctoral Fellow Immunology, Washington State University 2004
  • Ph.D. Immunology, Washington State University 2002
  • B.S. Biochemistry and Parasitology, University of Nairobi, Kenya 1990

Scholarly Interests

I am interested in the development of vaccines and adjuvants for the improvement of animal and human health. Many vaccine development studies conducted in in-bred mice have generated promising data. However, these outcomes have not been reproducible in humans and in livestock as well as in companion animals, the actual hosts that require protection. My current research is focused on the development of contemporary strategies for improving vaccine efficacy in outbred species. Studies are primarily directed at optimizing in vivo antigen presentation by dendritic cells following immunization. Dendritic cells are the most potent antigen presenting cells that are capable of stimulating naïve T cells to become antigen-specific effectors. In addition, I am evaluating defined dendritic cell activation factors for their potency in enhancing vaccine immunogenicity for adjuvant development. The major on-going funded efforts are directed at generating vaccines for effective protection of neonates against Bovine Viral Diarrhea Virus and for protection of swine against African swine fever virus. Development of safe and affordable immunizations strategies will enhance animal well-being and thereby improve human life.

Request Update